CGCABLE
834639
KLT
831689
DAYU BIOLOGICAL
871970
4
Fujian Superpipe
300198
5
WuHan Hvsen Biotechnology
300871
US Stock MarketDetailed Quotes
LADX LadRx
- 1.530000
- 0.0000000.00%
15min DelayClose Mar 20 10:32 ET
757.49KMarket Cap-0.26P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open1.530000Pre Close0.00Turnover0.00%Turnover Ratio2.25P/E (Static)495.09KShares3.50000052wk High-0.43P/B748.41KFloat Cap0.46210052wk Low--Dividend TTM489.16KShs Float162225.000000Historical High--Div YieldTTM0.00%Amplitude0.462100Historical Low--Avg Price1Lot Size
LadRx News
LadRx | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(0%),Steven Boyd(0%)
LadRx | 4: Statement of changes in beneficial ownership of securities-Officer CALOZ JOHN Y
LadRx | 4: Statement of changes in beneficial ownership of securities-Director Simpson Jennifer K.
LadRx | 4: Statement of changes in beneficial ownership of securities-Officer Snowdy Stephen
LadRx | 4: Statement of changes in beneficial ownership of securities-Director Claiborne Cary J
LadRx | 4: Statement of changes in beneficial ownership of securities-Director Caldwell Joel K
LadRx | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
CytRx Corp | 3: Initial statement of beneficial ownership of securities-Director Claiborne Cary J
CytRx Corp | D/A: Filing D (Amendment)
CytRx Corp | SC 13G: Statement of acquisition of beneficial ownership by individuals-Armistice Capital, LLC(9.99%),Steven Boyd(9.99%)
CytRx Corp | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Snowdy Stephen
CytRx Corp | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer Snowdy Stephen
CytRx Corp | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Simpson Jennifer K.
CytRx Corp | 4: Statement of changes in beneficial ownership of securities
CytRx Corp | 3: Initial statement of beneficial ownership of securities
CytRx Corp | D: Filing D
CytRx Corp | 4: Statement of changes in beneficial ownership of securities
CytRx Corp | 4: Statement of changes in beneficial ownership of securities
CytRx Corp | 4: Statement of changes in beneficial ownership of securities
CytRx Corp | 4: Statement of changes in beneficial ownership of securities
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call